Literature DB >> 22218610

Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.

Fabrizio Carta1, Mayank Aggarwal, Alfonso Maresca, Andrea Scozzafava, Robert McKenna, Claudiu T Supuran.   

Abstract

The zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1) is inhibited by several classes of zinc-binders (sulfonamides, sulfamates, and sulfamides) as well as by compounds which do not interact with the metal ion (phenols, polyamines and coumarins). Here we report a new class of potent CA inhibitors which bind the zinc ion: the dithiocarbamates (DTCs). They coordinate to the zinc ion from the enzyme active site in monodentate manner and establish many favorable interactions with amino acid residues nearby. Several low nanomolar CA I, II and IX inhibitors were detected. This journal is © The Royal Society of Chemistry 2012

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218610     DOI: 10.1039/c2cc16395k

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  29 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Identification of metal dithiocarbamates as a novel class of antileishmanial agents.

Authors:  Dhiman Sankar Pal; Dipon Kumar Mondal; Rupak Datta
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

3.  New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII.

Authors:  Rita Meleddu; Simona Distinto; Filippo Cottiglia; Rossella Angius; Pierluigi Caboni; Andrea Angeli; Claudia Melis; Serenella Deplano; Stefano Alcaro; Francesco Ortuso; Claudiu T Supuran; Elias Maccioni
Journal:  ACS Med Chem Lett       Date:  2020-02-13       Impact factor: 4.345

4.  Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.

Authors:  Johannes Karges; Ryjul W Stokes; Seth M Cohen
Journal:  ACS Med Chem Lett       Date:  2022-02-24       Impact factor: 4.345

5.  Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris.

Authors:  Ashok Aspatwar; Harlan Barker; Heidi Aisala; Ksenia Zueva; Marianne Kuuslahti; Martti Tolvanen; Craig R Primmer; Jaakko Lumme; Alessandro Bonardi; Amit Tripathi; Seppo Parkkila; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

6.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

7.  Insights towards sulfonamide drug specificity in α-carbonic anhydrases.

Authors:  Mayank Aggarwal; Bhargav Kondeti; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2012-08-28       Impact factor: 3.641

8.  Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae.

Authors:  Alessio Nocentini; Chad S Hewitt; Margaret D Mastrolorenzo; Daniel P Flaherty; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 9.  Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors.

Authors:  Melissa A Pinard; Brian Mahon; Robert McKenna
Journal:  Biomed Res Int       Date:  2015-02-24       Impact factor: 3.411

10.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.